IMA Q1 2021 Earnings — ImageneBio Inc Revenue & Financial Results | Market Cap Arena

IMAImageneBio Inc

$69M

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M+7.7% YoY

Gross Profit

-$7M-188.5% margin

Operating Income

-$10M-279.8% margin

Net Income

-$10M-279.7% margin

EPS (Diluted)

$-0.39

QoQ Revenue Growth

+5244.6%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$14M

Stock-Based Comp.

$885,000

Balance Sheet

Total Assets

$294M

Total Liabilities

$66M

Stockholders' Equity

$228M

Cash & Equivalents

$281M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$3M	+7.7%
Gross Profit	-$7M	-$5M	-40.3%
Operating Income	-$10M	-$7M	-35.5%
Net Income	-$10M	-$7M	-39.9%